Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of Montelukast in Eosinophilic Esophagitis

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Jeffrey A Alexander, Mayo Clinic Identifier:
First received: August 1, 2007
Last updated: November 2, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)